Cannabis and Paediatric Pain | Pain #3.8

Learning Objectives:

  • Describe the only medical condition presenting in pediatric patients that has strong evidence in the literature to support the use of cannabis as a therapeutic agent.
  • Describe the biological vulnerabilities of the the developing brain in children and adolescents when exposed to regular cannabis use.
  • Discuss specific mental health diagnoses that may more prevalent in children or adolescents exposed to regular use of cannabis.

Deepa Kattail, MD, MHS, FAAP, McMaster Children’s Hospital

Dr. Deepa Kattail is a board certified in anesthesiology and pediatric anesthesiology by the American Board of Anesthesiology and is a subspecialty fellow of the American Academy of Pediatrics. Her post-graduate clinical training included an anesthesia residency at Rush Medical Center in Chicago and a fellowship in pediatric anesthesiology at Johns Hopkins Hospital. She is actively involved in the Society of Pediatric Pain Medicine and is currently chair of the communications committee. Currently, she is a staff physician at McMaster Children’s Hospital and divides her time between pediatric anesthesiology, the pediatric chronic pain program, academic and research activities at McMaster University. Her research interests are focused on clinical aspects of pediatric pain.

Session Materials

You must be logged in to view this content.